Bundle 02 (2024)

Enrollment for this course is now closed, and its accreditation has ended.

Enroll in the current and accredited iteration of the COH/VA course if you would like to earn credit and a certificate of completion.

image

Instruction
3 Learning Modules
image

Time
2.25 Hours
image

Tasks
3 Quizzes

The Fundamentals of GCRA

  • Describe fundamentals of the genetic cancer risk assessment (GCRA) process.
  • Take a comprehensive cancer family history.
  • Explain the importance of and strategies for confirming key cancers.
  • Identify sporadic, familial, and hereditary cancer patterns.

Documenting the Cancer Family History

  • Recognize the importance of eliciting, documenting and verifying the patient family history.
  • Collect family history information, focusing on details and questions relevant to cancer history documentation.
  • Identify questionable or incomplete information that will need further verification to assess cancer risk in the family.
  • Draw a 3-4 generation pedigree using standard pedigree nomenclature and symbols.
  • Demonstrate skills associated with proficiency in collecting and documenting the family history of cancers.

Reading the Pathology Report through the Genomics Lens

  • Apply reading and interpreting pathology reports to define cancer stage and extract information on histology/molecular features.
  • Describe the roles of other diagnostic data (imaging, CT scans, blood markers).

Bita Nehoray, MS, CGC

Manager, Genetic Counselor

City of Hope

Bita Nehoray, MS, CGC, is a licensed board-certified genetic counselor specializing in cancer genetics. She received her Master’s degree in Human Genetics and Genetic Counseling from Stanford University. Ms. Nehoray joined the City of Hope Division of Clinical Cancer Genomics in 2012, where she provides cancer genetics services for patients and families suspected to have a hereditary predisposition to cancer, with a focus in Li-Fraumeni syndrome and clonal hematopoiesis of indeterminate potential. Current research projects include understanding cancer risk, penetrance, prevalence, and clinical outcomes for individuals with TP53 pathogenic variants as part of the LiFT UP study, evaluating the use of whole body MRI and liquid biopsy for early cancer detection, chatbot use for disclosure of germline genetic test results, and assessing community-based provider experiences with TP53 results on germline testing. She also serves on the genetic counseling advisory committee for the Li-Fraumeni Syndrome Association, the ClinGen TP53 Variant Curation Expert Panel, and the California Advisory Council for Sharsheret. She is faculty for the City of Hope Intensive Course in Genetic Cancer Risk Assessment. She is an active member of the National Society of Genetic Counselors and Southern California Genetic Counselors.

Sandra Dreike, MS, CGC

Manager, Genetic Counselor

City of Hope

SANDRA DREIKE, MS, CGC is a licensed board-certified genetic counselor who specializes in cancer genetics. Sandra joined the City of Hope Division of Clinical Cancer Genomics in 2019, where she provides genetic counseling and cancer genetic risk assessments as a Senior Genetic Counselor. She received her Master of Science degree is Genetic Counseling from University of California, Irvine and her bachelor’s degree in Biology from California Polytechnic State University, San Luis Obispo. She previously practiced as a genetic counselor in Honolulu, HI where she specialized in cancer genetics and general pediatric and adult genetics. In addition to patient care she is a faculty member of the City of Hope Intensive Course and Clinical Cancer Genomics Community of Practice, and research. Sandra is a member of the National Society of Genetic Counselors (NSGC) and Southern California Genetic Counselors (SCGC).

Components visible upon registration.